Repligen Corp. Company Profile (NASDAQ:RGEN)

About Repligen Corp.

Repligen Corp. logoRepligen Corporation is a bioprocessing company. The Company is focused on the development, production and commercialization of products used in the process of manufacturing biologic drugs (bioprocessing). The Company is a manufacturer of both native and recombinant forms of Protein A, critical reagents used in biomanufacturing to separate and purify monoclonal antibodies, a type of biologic drug. The Company also supplies several growth factor products, Alternating Tangential Flow (ATF) System products and cell filtration products used to increase cell culture productivity during the bioproduction process. The Company has developed a series of OPUS chromatography columns for use in clinical-scale manufacturing. The Company manufactures and sells Protein A and growth factors to life sciences companies under long-term supply agreements and sells its chromatography columns, as well as media and quality test kits.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: RGEN
  • CUSIP: 75991610
Key Metrics:
  • Previous Close: $31.71
  • 50 Day Moving Average: $31.74
  • 200 Day Moving Average: $27.55
  • 52-Week Range: $20.07 - $36.00
  • Trailing P/E Ratio: 126.84
  • Foreward P/E Ratio: 58.72
  • P/E Growth: 2.82
  • Market Cap: $1.07B
  • Outstanding Shares: 33,786,000
  • Beta: 1.29
  • Net Margins: 8.69%
  • Return on Equity: 10.74%
  • Return on Assets: 8.05%
  • Debt-to-Equity Ratio: 0.57%
  • Current Ratio: 10.21%
  • Quick Ratio: 9.12%
Additional Links:
Companies Related to Repligen Corp.:

Analyst Ratings

Consensus Ratings for Repligen Corp. (NASDAQ:RGEN) (?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $28.00 (11.70% downside)

Analysts' Ratings History for Repligen Corp. (NASDAQ:RGEN)
DateFirmActionRatingPrice TargetDetails
6/13/2016Jefferies GroupReiterated RatingHold$28.00View Rating Details
2/22/2016Craig HallumInitiated CoverageBuyView Rating Details
(Data available from 9/28/2014 forward)


Earnings History for Repligen Corp. (NASDAQ:RGEN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2016Q216$0.13$0.16$24.75 million$29.20 millionViewN/AView Earnings Details
5/5/2016Q116$0.10$0.12$22.54 million$25.10 millionViewN/AView Earnings Details
2/25/2016Q415$0.07$0.07$19.84 million$21.40 millionViewListenView Earnings Details
11/5/2015Q315$0.08$0.08$20.50 million$19.80 millionViewN/AView Earnings Details
8/6/2015Q215$0.08$0.11$20.05 million$21.50 millionViewN/AView Earnings Details
5/7/2015Q115$0.07$0.09$18.20 million$20.82 millionViewN/AView Earnings Details
3/13/2015Q414$0.04($0.01)$14.70 million$15.40 millionViewN/AView Earnings Details
11/6/2014Q314$0.04$0.04$15.60 million$15.30 millionViewN/AView Earnings Details
8/11/2014Q114$0.06$0.09$14.90 million$15.60 millionViewN/AView Earnings Details
5/8/2014Q1$0.07$0.13$15.14 million$16.33 millionViewListenView Earnings Details
3/6/2014Q413$0.14$0.10$15.88 million$10.40 millionViewListenView Earnings Details
11/7/2013Q313$0.13$0.18$16.27 million$18.80 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.10$0.14$15.97 million$17.50 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.07$12.82 million$16.46 millionViewListenView Earnings Details
11/8/2012Q312$0.06$8.63 million$15.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Repligen Corp. (NASDAQ:RGEN)
Current Year EPS Consensus Estimate: $0.44 EPS
Next Year EPS Consensus Estimate: $0.54 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.10$0.10$0.10
Q2 20161$0.12$0.12$0.12
Q3 20161$0.11$0.11$0.11
Q4 20161$0.12$0.12$0.12
Q1 20171$0.12$0.12$0.12
Q2 20171$0.15$0.15$0.15
Q3 20171$0.11$0.11$0.11
Q4 20171$0.12$0.12$0.12
(Data provided by Zacks Investment Research)


Dividend History for Repligen Corp. (NASDAQ:RGEN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Repligen Corp. (NASDAQ:RGEN)
Insider Ownership Percentage: 2.30%
Institutional Ownership Percentage: 89.38%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/14/2016Thomas F Ryan JrDirectorSell2,700$32.58$87,966.00View SEC Filing  
6/30/2016Thomas F Ryan JrDirectorSell5,000$26.60$133,000.00View SEC Filing  
6/28/2016Thomas F Ryan JrDirectorSell10,000$24.59$245,900.00View SEC Filing  
5/11/2016Howard BenjaminVPSell2,889$26.72$77,194.08View SEC Filing  
6/9/2015Howard BenjaminVPSell35,000$38.14$1,334,900.00View SEC Filing  
5/11/2015Walter C HerlihyCEOSell104,569$37.94$3,967,347.86View SEC Filing  
5/8/2015Thomas F Ryan JrDirectorSell20,000$37.19$743,800.00View SEC Filing  
3/23/2015Walter C HerlihyCEOSell24,536$31.78$779,754.08View SEC Filing  
3/19/2015James R RuscheSVPSell14,650$33.30$487,845.00View SEC Filing  
3/19/2015Thomas F Ryan JrDirectorSell10,000$32.62$326,200.00View SEC Filing  
3/19/2015Walter C HerlihyCEOSell49,695$33.08$1,643,910.60View SEC Filing  
3/18/2015Howard BenjaminVPSell15,795$32.63$515,390.85View SEC Filing  
11/19/2014Walter C HerlihyCEOSell51,386$23.43$1,203,973.98View SEC Filing  
11/13/2014Thomas F Ryan JrDirectorSell10,000$23.81$238,100.00View SEC Filing  
11/11/2014Howard BenjaminVPSell30,000$23.56$706,800.00View SEC Filing  
11/10/2014Michael A GriffithDirectorSell23,342$22.90$534,531.80View SEC Filing  
8/13/2014Howard BenjaminVPSell40,000$20.34$813,600.00View SEC Filing  
6/27/2014Thomas F Ryan JrDirectorSell10,000$22.41$224,100.00View SEC Filing  
6/24/2014Thomas F Ryan JrDirectorSell10,000$21.78$217,800.00View SEC Filing  
6/11/2014Walter C HerlihyCEOSell60,335$20.11$1,213,336.85View SEC Filing  
6/9/2014James R RuscheSVPSell30,000$20.19$605,700.00View SEC Filing  
6/6/2014Daniel P WittSVPSell47,709$20.56$980,897.04View SEC Filing  
4/15/2014Daniel P WittSVPBuy10,000$3.05$30,500.00View SEC Filing  
8/8/2013James R RuscheSVPSell30,000$10.01$300,300.00View SEC Filing  
6/21/2013Karen A DawesDirectorBuy1,000$7.70$7,700.00View SEC Filing  
5/17/2013Thomas F Ryan JrDirectorSell21,000$8.97$188,370.00View SEC Filing  
5/15/2013Thomas F Ryan JrDirectorSell86,039$9.01$775,211.39View SEC Filing  
5/15/2013Walter C HerlihyCEOSell40,000$8.97$358,800.00View SEC Filing  
9/21/2012Glenn L Md CooperDirectorBuy10,000$6.09$60,900.00View SEC Filing  
8/16/2012Michael A GriffithDirectorBuy2,000$4.88$9,760.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Repligen Corp. (NASDAQ:RGEN)
DateHeadline logoRepligen Corporation (NASDAQ:RGEN) Mean Price Target At $33.666 (NASDAQ:RGEN) - September 27 at 11:39 AM logoRepligen Corporation (NASDAQ:RGEN) Mean Price Target At $33.666 - (NASDAQ:RGEN) - September 26 at 11:51 AM logoShares Of Repligen Corporation (NASDAQ:RGEN) Expected To Hit $37 - Investor Newswire (NASDAQ:RGEN) - September 25 at 6:14 PM logoRepligen Shares Up 24.6% Since SmarTrend's Buy Recommendation (RGEN) (NASDAQ:RGEN) - September 23 at 3:15 PM logoRepligen Corporation (NASDAQ:RGEN) Trading Down – Insiders Selling, Short Interest Growing (NASDAQ:RGEN) - September 16 at 6:49 PM logoRepligen Has Returned 27.2% Since SmarTrend Recommendation (RGEN) (NASDAQ:RGEN) - September 16 at 10:35 AM logoRepligen Has More Upside Ahead (NASDAQ:RGEN) - September 14 at 11:25 AM
News IconStock Up Over the Past Five Trading Sessions: Repligen Corporation (NASDAQ:RGEN) - Post News (NASDAQ:RGEN) - September 13 at 11:55 AM
News IconPlacing Repligen Corporation (NASDAQ:RGEN) Shares Under the Microscope - Post News (NASDAQ:RGEN) - September 9 at 6:39 PM logoREPLIGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (NASDAQ:RGEN) - September 2 at 6:56 PM logoRepligen to Present at Baird Global Healthcare Conference 2016 (NASDAQ:RGEN) - September 1 at 10:11 AM logoRepligen Has Returned 19.8% Since SmarTrend Recommendation (RGEN) (NASDAQ:RGEN) - August 30 at 10:22 AM
News IconGILD Stock: Is This Tiny Company the Next Gilead Sciences, Inc.? (NASDAQ:RGEN) - August 26 at 10:01 AM
News IconRepligen Corporation (NASDAQ:RGEN) Stock Update: Wall Street ... - Post News (NASDAQ:RGEN) - August 22 at 7:00 PM logoWill Repligen Corporation (NASDAQ:RGEN) Hit $37 Price Target? - Investor Newswire (NASDAQ:RGEN) - August 22 at 11:44 AM logoRepligen Corporation (NASDAQ:RGEN) Stock Price Likely To Reach $33.666: Wall Street - (NASDAQ:RGEN) - August 22 at 11:44 AM logo21.5% Return Seen to Date on SmarTrend Repligen Call (RGEN) (NASDAQ:RGEN) - August 18 at 10:09 AM logoHere’s The Growth Forecast For Repligen Corporation (NASDAQ:RGEN) (NASDAQ:RGEN) - August 16 at 10:27 AM logoHere's The Growth Forecast For Repligen Corporation (NASDAQ:RGEN) - (NASDAQ:RGEN) - August 15 at 7:31 PM logoREPLIGEN CORP Financials (NASDAQ:RGEN) - August 11 at 7:39 PM logoBrokerages Set a Mean Target Price Of $33.666 For Repligen Corporation (NASDAQ:RGEN) (NASDAQ:RGEN) - August 9 at 7:24 PM logoRepligen Corp. :RGEN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NASDAQ:RGEN) - August 9 at 7:24 PM logoCommit To Buy Repligen Corp. At $25, Earn 12.9% Annualized Using Options (NASDAQ:RGEN) - August 8 at 7:20 PM logoStrong Sell Calls For Repligen Corporation (NASDAQ:RGEN) At 0 - Investor Newswire (NASDAQ:RGEN) - August 7 at 6:44 PM logoEdited Transcript of RGEN earnings conference call or presentation 4-Aug-16 12:30pm GMT (NASDAQ:RGEN) - August 5 at 10:07 AM logoRepligen Corporation: Repligen Reports Second Quarter 2016 Financial Results (NASDAQ:RGEN) - August 4 at 10:18 AM logoRepligen beats Street 2Q forecasts (NASDAQ:RGEN) - August 4 at 10:18 AM logoShort Interest Moves 24% Higher For RGEN (NASDAQ:RGEN) - July 27 at 7:31 PM logoRepligen to Report Second Quarter 2016 Financial Results (NASDAQ:RGEN) - July 27 at 8:08 AM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Repligen Corporation (NASDAQ:RGEN) - TGP (NASDAQ:RGEN) - July 22 at 10:03 AM
News IconRepligen Corporation (NASDAQ:RGEN) Shorted Shares Increased 6.07% After Market Selling - Consumer Eagle (NASDAQ:RGEN) - July 22 at 10:03 AM
News IconShares Lower on the Year Repligen Corporation (NASDAQ:RGEN) - Press Telegraph (NASDAQ:RGEN) - July 19 at 8:05 AM
News IconRepligen Corporation (NASDAQ:RGEN) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:RGEN) - July 19 at 8:05 AM
News IconShare Performance Summary for: Repligen Corporation (NASDAQ:RGEN) - Press Telegraph (NASDAQ:RGEN) - July 19 at 8:05 AM
News IconRepligen Corporation (NASDAQ:RGEN) Short Interest Decreased By 1.84% - Press Telegraph (NASDAQ:RGEN) - July 19 at 8:05 AM logoWhat's The Growth Forecast For Repligen Corporation (NASDAQ:RGEN)? - (NASDAQ:RGEN) - July 19 at 8:05 AM
News IconShares Experiencing a Downtrend: Repligen Corporation (NASDAQ:RGEN) - TGP (NASDAQ:RGEN) - July 17 at 6:32 PM
News IconShares Moving Down on the Week: Repligen Corporation (NASDAQ:RGEN) - Engelwood Daily (NASDAQ:RGEN) - July 17 at 6:32 PM
News IconReview on Stock Valuation for: Repligen Corporation (NASDAQ:RGEN) - TGP (NASDAQ:RGEN) - July 17 at 6:32 PM logoNext Weeks Broker Price Targets For Repligen Corporation (NASDAQ:RGEN) - Fiscal Standard (NASDAQ:RGEN) - July 17 at 6:32 PM
News IconBearish Chart Formation for Repligen Corporation After Forming Bearish Multiple Bottom Pattern - Consumer Eagle (NASDAQ:RGEN) - July 14 at 7:22 PM
News IconStock Moving Up This Week: Repligen Corporation (NASDAQ:RGEN) - Telanagana Press (NASDAQ:RGEN) - July 12 at 7:23 PM
News IconRepligen Corporation (NASDAQ:RGEN) Sellers Covered 1.84% of Their Shorts - Consumer Eagle (NASDAQ:RGEN) - July 12 at 7:23 PM
News IconStock on the Rise for the Quarter: Repligen Corporation (NASDAQ:RGEN) - Engelwood Daily (NASDAQ:RGEN) - July 11 at 11:45 AM
News IconCompany Stock Focus for Repligen Corporation (NASDAQ:RGEN): Which Way Will Shares Head? - Press Telegraph (NASDAQ:RGEN) - July 11 at 11:45 AM logoIs $44 Within Reach For Repligen Corporation (NASDAQ:RGEN)? - Investor Newswire (NASDAQ:RGEN) - July 11 at 11:45 AM
News IconStock Performance Rundown on: Repligen Corporation (NASDAQ:RGEN) - Press Telegraph (NASDAQ:RGEN) - July 11 at 11:45 AM logoRepligen Corporation (NASDAQ:RGEN)'s Growth Projection - (NASDAQ:RGEN) - July 11 at 11:45 AM logoBroker Outlook For Repligen Corporation (NASDAQ:RGEN) - Fiscal Standard (NASDAQ:RGEN) - July 9 at 10:13 AM
News IconStock Accelerating: Repligen Corporation (NASDAQ:RGEN) - Telanagana Press (NASDAQ:RGEN) - July 6 at 7:25 PM


Repligen Corp. (NASDAQ:RGEN) Chart for Wednesday, September, 28, 2016

Last Updated on 9/28/2016 by Staff